BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors

CNS Oncology April 2017, Vol. 6, No. 2, Pages 95-99.


from Cancer via ola Kala on Inoreader http://ift.tt/2pJJZTO
via IFTTT